@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-D5BZWFDV-F mesh:pharmacologicalAction jvr:-P2SS2F17-G .
jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-QD114KHN-N mesh:pharmacologicalAction jvr:-P2SS2F17-G .
jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z3X6PV7Z-T
  skos:prefLabel "Therapeutic Uses"@en, "Utilisations thérapeutiques"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-P2SS2F17-G .

jvr:-MCFWCTDM-Z mesh:pharmacologicalAction jvr:-P2SS2F17-G .
jvr:-G6D80JXN-6 mesh:pharmacologicalAction jvr:-P2SS2F17-G .
jvr:-XR6MT7ZV-V
  skos:prefLabel "Cardiotoniques"@fr, "Cardiotonic Agents"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr:-FG8LP9J8-Q
  skos:prefLabel "Antihypertensive Agents"@en, "Antihypertenseurs"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W8MNH2H7-8
  skos:prefLabel "Inhibiteurs des canaux calciques"@fr, "Calcium Channel Blockers"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr:-ZQS2168K-V
  skos:prefLabel "Inhibiteurs des canaux potassiques"@fr, "Potassium Channel Blockers"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr:-TC4H7320-6
  skos:prefLabel "Sodium Channel Blockers"@en, "Bloqueurs de canaux sodiques"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr: a skos:ConceptScheme .
jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-PTD6SZKZ-V
  skos:prefLabel "Cardioplegic Solutions"@en, "Solutions cardioplégiques"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-PF128B09-N
  skos:prefLabel "Sympathomimétiques"@fr, "Sympathomimetics"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-P2SS2F17-G .

jvr:-DG3TD8DB-1
  skos:prefLabel "Fibrinolytic Agents"@en, "Fibrinolytiques"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W15VZJCF-0
  skos:prefLabel "Natriuretic Agents"@en, "Natriurétiques"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R9SB4WRS-X
  skos:prefLabel "Vasoconstricteurs"@fr, "Vasoconstrictor Agents"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr:-CRP9WRZZ-S mesh:pharmacologicalAction jvr:-P2SS2F17-G .
jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S9CF8MNQ-W
  skos:prefLabel "Solutions sclérosantes"@fr, "Sclerosing Solutions"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-K9FBN5C5-1
  skos:prefLabel "Vasodilator Agents"@en, "Vasodilatateurs"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-LS0SSBHQ-R
  skos:prefLabel "Anti-Arrhythmia Agents"@en, "Antiarythmiques"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .

jvr:-J54HH63X-4 mesh:pharmacologicalAction jvr:-P2SS2F17-G .
jvr:-FK1JHJRR-0 mesh:pharmacologicalAction jvr:-P2SS2F17-G .
jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-P2SS2F17-G
  skos:narrower jvr:-TC4H7320-6, jvr:-R9SB4WRS-X, jvr:-DG3TD8DB-1, jvr:-LS0SSBHQ-R, jvr:-FG8LP9J8-Q, jvr:-W15VZJCF-0, jvr:-XR6MT7ZV-V, jvr:-ZQS2168K-V, jvr:-K9FBN5C5-1, jvr:-S9CF8MNQ-W, jvr:-PTD6SZKZ-V, jvr:-W8MNH2H7-8, jvr:-GM1QBJXR-9 ;
  mesh:allowableQualifier jvr:-WK5F724J-1, jvr:-CB30NGKB-3, jvr:-G30ZJ446-J, jvr:-HQRFT0C6-B, jvr:-W6SQV79N-S, jvr:-M63HSDM7-1, jvr:-Q3979798-W, jvr:-FWD2BGQ0-9, jvr:-BT300B3G-Q, jvr:-D0F21513-5, jvr:-R3QWLHRG-V, jvr:-XV06LPML-W, jvr:-S0CS1X5R-5, jvr:-H7K65Q8S-Z, jvr:-T9HQD7ST-J, jvr:-NB0XHT3S-N, jvr:-THHNVC7V-3, jvr:-SBNWSM1T-R, jvr:-R0ZCQ8X6-J, jvr:-NHL3D2X0-S, jvr:-L6C0XPHT-4, jvr:-NKM836P1-M, jvr:-NFTHND7Q-8, jvr:-TJHVZCRZ-0 ;
  skos:prefLabel "Cardiovascular Agents"@en, "Agents cardiovasculaires"@fr ;
  dc:created "1999-01-01"^^xsd:date ;
  a mesh:Descriptor, skos:Concept ;
  skos:altLabel "Cardiovascular Drug"@en, "Cardiovascular Drugs"@en, "Médicaments cardiovasculaires"@fr, "Cardiovascular Agent"@en ;
  skos:broader jvr:-Z3X6PV7Z-T ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D002317> ;
  skos:hiddenLabel "Cardioactive Agent"@en, "Cardioactive Drugs"@en, "Cardioactive Agents"@en, "Cardioactive Drug"@en ;
  dc:established "1979-01-01"^^xsd:date ;
  dc:modified "2021-06-30"^^xsd:date ;
  skos:inScheme jvr: ;
  skos:definition "Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume."@en ;
  skos:related jvr:-PF128B09-N .

jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-GM1QBJXR-9
  skos:prefLabel "Nitric Oxide Donors"@en, "Donneur d'oxyde nitrique"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-P2SS2F17-G .